文献速递白血病造血干细胞移植与细胞治疗

活化的基质细胞通过线粒体转移保护急性淋巴细胞白血病细胞免受氧化应激

Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
PubMed 文献 · Blood · 2019-01-01

该研究探讨了成人急性淋巴细胞白血病(ALL)的间充质基质细胞(MSC)微环境。研究发现,ALL患者骨髓来源的MSC常呈现活化的癌症相关成纤维细胞表型;化疗药物阿糖胞苷(AraC)和柔红霉素(DNR)可诱导正常MSC活化,活化的MSC通过隧道纳米管(TNT)向ALL细胞转移线粒体,从而阻止治疗诱导的凋亡和死亡。抑制线粒体转移或使用皮质类固醇可阻断该保护作用。

要点

  • ALL患者骨髓MSC常呈活化癌症相关成纤维细胞表型。
  • AraC和DNR可诱导MSC活化,抗氧化剂N-乙酰半胱氨酸可阻断。
  • 活化MSC经TNT向ALL细胞转移线粒体,防止凋亡。

核心结论

  • 活化的MSC通过TNT向ALL细胞转移线粒体,保护其免受ROS诱导化疗的凋亡。
  • 抑制线粒体转移或阻止MSC活化可消除这种保护作用。

研究设计与样本

  • 使用基因表达谱、细胞因子/趋化因子定量、流式细胞术和多种成像技术研究成人ALL患者骨髓原代MSC。
  • 在体外共培养模型和 murine NSG 播散性SEM细胞衍生ALL模型中验证。

主要发现

  • ALL患者原代骨髓MSC频繁呈现活化的癌症相关成纤维细胞表型。
  • AraC和DNR诱导正常原代人MSC和HS27a细胞活化,N-乙酰半胱氨酸可阻断。
  • 化疗活化的HS27a细胞通过TNT转移线粒体,防止ALL靶细胞凋亡和死亡。
  • 选择性线粒体耗竭或微管抑制剂(如长春新碱)干扰TNT形成,可减少线粒体转移并阻止MSC的挽救功能。
  • 皮质类固醇可阻止MSC活化;在NSG模型中,AraC(而非VCR)诱导MSC活化、线粒体转移和线粒体质量增加。

临床怎么用

  • 靶向MSC活化或线粒体转移可能改善ALL治疗,尤其是针对残留病灶。
  • 皮质类固醇或微管抑制剂可能通过抑制MSC活化或TNT形成增强化疗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated and modeled the mesenchymal stromal cell (MSC) niche in adult acute lymphoblastic leukemia (ALL). We used gene expression profiling, cytokine/chemokine quantification, flow cytometry, and a variety of imaging techniques to show that MSCs, directly isolated from the primary bone marrow specimens of patients with ALL, frequently adopted an activated, cancer-associated fibroblast phenotype. Normal, primary human MSCs and the MSC cell line HS27a both were activated de novo, when exposed to the reactive oxygen species (ROS)-inducing chemotherapy agents cytarabine (AraC) and daunorubicin (DNR), a phenomenon blocked by the antioxidant N-acetyl cysteine. Chemotherapy-activated HS27a cells were functionally evaluated in a coculture model with ALL targets. Activated MSCs prevented therapy-induced apoptosis and death in ALL targets, via mitochondrial transfer through tunneling nanotubes (TNTs). Reduction of mitochondrial transfer by selective mitochondrial depletion or interference with TNT formation by microtubule inhibitors, such as vincristine (VCR), prevented the "rescue" function of activated MSCs. Corticosteroids, also a mainstay of ALL therapy, prevented the activation of MSCs. We also demonstrated that AraC (but not VCR) induced activation of MSCs, mitochondrial transfer, and mitochondrial mass increase in a murine NSG model of disseminated SEM cell-derived ALL, wherein CD19+ cells closely associated with nestin+ MSCs after AraC, but not in the other conditions. Our data propose a readily clinically exploitable mechanism for improving treatment of ALL, in which traditional ROS-inducing chemotherapies are often ineffective at eradicating residual disease, despite efficiently killing the bulk population.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Burt R, Dey A, Aref S, et al. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress. Blood. 2019. PMID: 31501154. doi:10.1182/blood.2019001398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。